markets is the sole category represented across all 1 tracked stories. Compass Pathways plc is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Truecaller AB appears in 1 tracked Finance story from February 17, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Truecaller AB
markets is the sole category represented across all 1 tracked stories. Compass Pathways plc is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Truecaller AB appears in 1 tracked Finance story from February 17, 2026. The tracked stories average 9 original sources each.
Stories tracked
1
Sources per story
9
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Truecaller AB. Shared-story counts are live from our verified record — not editorial picks.
The equity markets are navigating a complex landscape of 'sell-the-news' reactions and extreme biotech volatility following a series of clinical and financial updates. While Compass Pathways surged on positive trial results, Ocular Therapeutix and Genmab faced significant selling pressure despite reaching key milestones.